tradingkey.logo
tradingkey.logo
Search

Lexeo Therapeutics Inc

LXEO
Add to Watchlist
4.360USD
-0.120-2.68%
Close 09-10 16:00ET
342.78MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.68%

5 Days

-9.92%

1 Month

-5.83%

6 Months

-39.44%

Year to Date

-56.09%

1 Year

-16.15%

Key Figures

4.430Open
4.440High
38.30KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
4.480Prev. Close
4.310Low
167.70KTurnover
LossP/E Static
1.46P/B
0.00%Div Yield TTM
-46.54%ROA
10.99052wk High
42.74Volume Ratio
-98.33MNet Profit
78.62MShares
-1.1260EPS TTM
--Beta
-54.75%ROE
3.99052wk Low
2.46%Amplitude
100.00%Gross Margin
342.78MMarket Cap
1.59Reward/Risk
4.86%Risk Rate
More news coming soon, stay tuned...

Lexeo Therapeutics Inc's Score

0.08vs previous score
Forecast9.20
Financial Health5.73
Technical4.89
Valuation Dimensions6.28
Institutional Confidence10.00
Risk Assessment4.47

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
Strong BuyCurrent Rating
21.556Target Price
+340.81%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy66666666
Buy44445555
Hold00000000
Sell00000000
Strong Sell00000000

Lexeo Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.30/-0.29
Revenue / Forecast
--/0.00

Lexeo Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolLXEO
Number of employees72
CountryUnited States of America

Ownership

ShareholdersProportion
Suvretta Capital Management, LLC7.23%
Janus Henderson Investors7.02%
RA Capital Management, LP6.37%
Paradigm BioCapital Advisors LP6.07%
Shareholder TypesProportion
Hedge Fund44.37%
Investment Advisor/Hedge Fund28.80%
Investment Advisor15.95%
Venture Capital11.10%

FAQs

What is the current price of Lexeo Therapeutics Inc (LXEO)?

The current price of Lexeo Therapeutics Inc (LXEO) is 4.36.

What is the symbol of Lexeo Therapeutics Inc?

The ticker symbol of Lexeo Therapeutics Inc is LXEO.

What is the 52-week high of Lexeo Therapeutics Inc?

The 52-week high of Lexeo Therapeutics Inc is 10.99.

What is the 52-week low of Lexeo Therapeutics Inc?

The 52-week low of Lexeo Therapeutics Inc is 3.99.

What is the market capitalization of Lexeo Therapeutics Inc?

The market capitalization of Lexeo Therapeutics Inc is 342.78M.

Is Lexeo Therapeutics Inc (LXEO) currently rated as Buy, Hold, or Sell?

According to analysts, Lexeo Therapeutics Inc (LXEO) has an overall rating of STRONG BUY, with a price target of 21.56.

What is the Earnings Per Share (EPS TTM) of Lexeo Therapeutics Inc (LXEO)?

The Earnings Per Share (EPS TTM) of Lexeo Therapeutics Inc (LXEO) is -1.13.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.